Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SEROQUEL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    2. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    3. DeVane, CL; Nemeroff, CB
      Clinical pharmacokinetics of quetiapine - An atypical antipsychotic

      CLINICAL PHARMACOKINETICS
    4. Wong, YWJ; Yeh, C; Thyrum, PT
      The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    5. Sajatovic, M; Brescan, DW; Perez, DE; DiGiovanni, SK; Hattab, H; Ray, JB; Bingham, CR
      Quetiapine alone and added to a mood stabilizer for serious mood disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    6. Jones, HM; Travis, MJ; Mulligan, R; Bressan, RA; Visvikis, D; Gacinovic, S; Ell, PJ; Pilowsky, LS
      In vivo 5-HT2A receptor blockade by quetiapine - An R91150 single photon emission tomography study

      PSYCHOPHARMACOLOGY
    7. Pandarakalam, JP
      Atypical neuroleptics

      HOSPITAL MEDICINE
    8. Reznik, I; Benatov, R; Sirota, P
      Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    9. Matheson, AJ; Lamb, HM
      Quetiapine - A review of its clinical potential in the management of psychotic symptoms in Parkinson's disease

      CNS DRUGS
    10. Madhusoodanan, S; Brenner, R; Alcantra, A
      Clinical experience with quetiapine in elderly patients with psychotic disorders

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    11. Fernandez, HH; Lannon, MC; Friedman, JH; Abbott, BP
      Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

      MOVEMENT DISORDERS
    12. Thyrum, PT; Wong, YWJ; Yeh, C
      Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    13. Vesely, C; Kufferle, B; Brucke, T; Kasper, S
      Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    14. Guan, HJ; Dai, J; Zhu, XZ
      Atypical antipsychotic effects of quetiapine fumarate in animal models

      ACTA PHARMACOLOGICA SINICA
    15. Barzega, G; Bogetto, F; Maina, G; Ravizza, L
      Quetiapine in schizophrenic patients: A high- and low-dose double-blind comparison

      EUROPEAN JOURNAL OF PSYCHIATRY
    16. McConville, BJ; Arvanitis, LA; Thyrum, PT; Yeh, C; Wilkinson, LA; Chaney, RO; Foster, KD; Sorter, MT; Friedman, LM; Brown, KL; Heubi, JE
      Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: An open-label trial in adolescents with psychotic disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    17. Garver, DL
      Review of quetiapine side effects

      JOURNAL OF CLINICAL PSYCHIATRY
    18. Tariot, PN; Salzman, C; Yeung, PP; Pultz, J; Rak, IW
      Long-term use of quetiapine in elderly patients with psychotic disorders

      CLINICAL THERAPEUTICS
    19. Dev, V; Raniwalla, J
      Quetiapine - A review of its safety in the management of schizophrenia

      DRUG SAFETY
    20. Yeung, PP; Tariot, PN; Schneider, LS; Salzman, C; Rak, IW
      Quetiapine for elderly patients with psychotic disorders

      PSYCHIATRIC ANNALS
    21. Keltner, NL; Coffeen, H; Johnson, JE
      Atypical antipsychotic drugs: Part II

      PERSPECTIVES IN PSYCHIATRIC CARE
    22. Porter, JH; Varvel, SA; Vann, RE; Philibin, SD; Wise, LE
      Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats

      PSYCHOPHARMACOLOGY
    23. Purdon, SE
      Cognitive improvement in schizophrenia with novel antipsychotic medications

      SCHIZOPHRENIA RESEARCH
    24. Fernandez, HH; Friedman, JH; Jacques, C; Rosenfeld, M
      Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

      MOVEMENT DISORDERS
    25. Hustey, FM
      Acute quetiapine poisoning

      JOURNAL OF EMERGENCY MEDICINE
    26. McManus, DQ; Arvanitis, LA; Kowalcyk, BB
      Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    27. Tariot, PN
      Treatment of agitation in dementia

      JOURNAL OF CLINICAL PSYCHIATRY
    28. Tandon, R; Milner, K; Jibson, MD
      Antipsychotics from theory to practice: Integrating clinical and basic data

      JOURNAL OF CLINICAL PSYCHIATRY
    29. Juncos, JL
      Management of psychotic aspects of Parkinson's disease

      JOURNAL OF CLINICAL PSYCHIATRY
    30. Tariot, PN
      The older patient: The ongoing challenge of efficacy and tolerability

      JOURNAL OF CLINICAL PSYCHIATRY
    31. Ike, N
      Delirium induced by quetiapine: A rare event?

      PSYCHIATRIC ANNALS
    32. GUNASEKARA NS; SPENCER CM
      QUETIAPINE - A REVIEW OF ITS USE IN SCHIZOPHRENIA

      CNS DRUGS
    33. CALEY CF; ROSENBAUM S
      FOCUS ON QUETIAPINE - THE 4TH ATYPICAL ANTIPSYCHOTIC

      Formulary
    34. HARMON TJ; BENITEZ JG; KRENZELOK EP; CORTESBELEN E
      LOSS OF CONSCIOUSNESS FROM ACUTE QUETIAPINE OVERDOSAGE

      Journal of toxicology. Clinical toxicology
    35. Degner, D; Ruther, E
      "Atypical" antipsychotic drugs in the treatment of schizophrenia

      NERVENHEILKUNDE
    36. GOREN JL; LEVIN GM
      QUETIAPINE, AN ATYPICAL ANTIPSYCHOTIC

      Pharmacotherapy
    37. CARASSO BS; BAKSHI VP; GEYER MA
      DISRUPTION IN PREPULSE INHIBITION AFTER ALPHA-1-ADRENOCEPTOR STIMULATION IN RATS

      Neuropharmacology
    38. SWERDLOW NR; BAKSHI V; WAIKAR M; TAAID N; GEYER MA
      SEROQUEL, CLOZAPINE AND CHLORPROMAZINE RESTORE SENSORIMOTOR GATING INKETAMINE TREATED RATS

      Psychopharmacology
    39. GOUDIE A; TAYLOR A
      COMPARATIVE CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF CLOZAPINE AND OTHER ANTIPSYCHOTICS IN RATS

      Psychopharmacology
    40. CASEY DE
      THE RELATIONSHIP OF PHARMACOLOGY TO SIDE-EFFECTS

      The Journal of clinical psychiatry
    41. ZENG XP; LE F; RICHELSON E
      MUSCARINIC M4 RECEPTOR ACTIVATION BY SOME ATYPICAL ANTIPSYCHOTIC-DRUGS

      European journal of pharmacology
    42. ARVANITIS LA; MILLER BG; BORISON RL; PITTS WM; SHARIF ZA; HAMNER MB; HERZ MI; TRUE JE; VELLIGAN D; KNESEVICH MA; SMALL J; STEINBOOK R; HERTZMAN M; KECK PE; NEWCOMER JW; GRACE J; ROTROSEN J; TANDON R; DOTT SG; FERGUSON JM; ADDINGTON DEN; MACEWAN GW; NAIR VNP; SHRIQUI CL; WILLIAMS R; DANIEL DG; SHEHI GM; PATTERSON WM; MERIDETH CH
      MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO

      Biological psychiatry
    43. PEUSKENS J; LINK CGG
      A COMPARISON OF QUETIAPINE AND CHLORPROMAZINE IN THE TREATMENT OF SCHIZOPHRENIA

      Acta psychiatrica Scandinavica
    44. KUFFERLE B; TAUSCHER J; ASENBAUM S; VESELY C; PODREKA I; BRUCKE T; KASPER S
      IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      Psychopharmacology
    45. CAREY GJ; BERGMAN J
      DISCRIMINATIVE-STIMULUS EFFECTS OF CLOZAPINE IN SQUIRREL-MONKEYS - COMPARISON WITH CONVENTIONAL AND NOVEL ANTIPSYCHOTIC DRUGS

      Psychopharmacology
    46. KERWIN R; TAYLOR D
      NEW ANTIPSYCHOTICS - A REVIEW OF THEIR CURRENT STATUS AND CLINICAL POTENTIAL

      CNS DRUGS
    47. ELLENBROEK BA; LUBBERS LJ; COOLS AR
      ACTIVITY OF SEROQUEL (ICI204,636) IN ANIMAL-MODELS FOR ATYPICAL PROPERTIES OF ANTIPSYCHOTICS - A COMPARISON WITH CLOZAPINE

      Neuropsychopharmacology
    48. BYMASTER FP; CALLIGARO DO; FALCONE JF; MARSH RD; MOORE NA; TYE NC; SEEMAN P; WONG DT
      RADIORECEPTOR BINDING PROFILE OF THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE

      Neuropsychopharmacology
    49. STIP E
      MEMORY IMPAIRMENT IN SCHIZOPHRENIA - PERSPECTIVES FROM PSYCHOPATHOLOGY AND PHARMACOTHERAPY

      Canadian journal of psychiatry
    50. BORISON RL; ARVANITIS LA; MILLER BG; ALPHS LD; CARMAN JS; DIAMOND B; GEWIRTZ G; HAMNER MB; HIRSHFIELD R; MCEVOY JP; MUKHERJEE S; NASRALLAH HA; OXENKRUG G; RYAN W; SMITH N; TAMMINGA C
      ICI-204,636, AN ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY IN A MULTICENTER, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    51. MARDER SR
      PHARMACOLOGICAL TREATMENT STRATEGIES IN ACUTE SCHIZOPHRENIA

      International clinical psychopharmacology
    52. TAMMINGA CA; LAHTI AC
      THE NEW-GENERATION OF ANTIPSYCHOTIC-DRUGS

      International clinical psychopharmacology
    53. HIRSCH SR; LINK CGG; GOLDSTEIN JM; ARVANITIS LA
      ICI-204,636 - A NEW ATYPICAL ANTIPSYCHOTIC DRUG

      British Journal of Psychiatry
    54. SKARSFELDT T
      DIFFERENTIAL EFFECT OF ANTIPSYCHOTICS ON PLACE NAVIGATION OF RATS IN THE MORRIS WATER MAZE - A COMPARATIVE-STUDY BETWEEN NOVEL AND REFERENCE ANTIPSYCHOTICS

      Psychopharmacology
    55. FULTON B; GOA KL
      ICI-204,636 - AN INITIAL APPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE TREATMENT OF SCHIZOPHRENIA

      CNS DRUGS
    56. LAHTI AC; TAMMINGA CA
      RECENT DEVELOPMENTS IN THE NEUROPHARMACOLOGY OF SCHIZOPHRENIA

      American journal of health-system pharmacy
    57. SEEMAN P
      THERAPEUTIC RECEPTOR-BLOCKING CONCENTRATIONS OF NEUROLEPTICS

      International clinical psychopharmacology
    58. GERLACH J; PEACOCK L
      NEW ANTIPSYCHOTICS - THE PRESENT STATUS

      International clinical psychopharmacology
    59. SKARSFELDT T
      DIFFERENTIAL-EFFECTS OF REPEATED ADMINISTRATION OF NOVEL ANTIPSYCHOTIC-DRUGS ON THE ACTIVITY OF MIDBRAIN DOPAMINE NEURONS IN THE RAT

      European journal of pharmacology
    60. WETZEL H; SZEGEDI A; HAIN C; WIESNER J; SCHLEGEL S; BENKERT O
      SEROQUEL (ICI-204-636), A PUTATIVE ATYPICAL ANTIPSYCHOTIC, IN SCHIZOPHRENIA WITH POSITIVE SYMPTOMATOLOGY - RESULTS OF AN OPEN CLINICAL-TRIAL AND CHANGES OF NEUROENDOCRINOLOGICAL AND EEG PARAMETERS

      Psychopharmacology
    61. SALLER CF; SALAMA AI
      SEROQUEL - BIOCHEMICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC

      Psychopharmacology
    62. GOLDSTEIN JM; LITWIN LC; SUTTON EB; MALICK JB
      SEROQUEL - ELECTROPHYSIOLOGICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC

      Psychopharmacology
    63. MIGLER BM; WARAWA EJ; MALICK JB
      SEROQUEL - BEHAVIORAL-EFFECTS IN CONVENTIONAL AND NOVEL TESTS FOR ATYPICAL ANTIPSYCHOTIC DRUG

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:41:52